TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
274,034
|
257,245
|
207,465 |
| Financial expenses |
23,675
|
42,304
|
47,207 |
| Earnings before taxes |
51,755
|
33,438
|
44,745 |
| Total assets |
488,310
|
454,485
|
481,574 |
| Current assets |
214,187
|
155,678
|
166,103 |
| Current liabilities |
36,971
|
24,758
|
29,969 |
| Equity capital |
320,153
|
284,758
|
277,035 |
| - share capital |
27,061
|
27,549
|
29,504 |
| Employees (average) | 39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.6%
|
62.7%
|
57.5% |
| Turnover per employee | 7,027 | ||
| Profit as a percentage of turnover |
18.9%
|
13.0%
|
21.6% |
| Return on assets (ROA) |
15.4%
|
16.7%
|
19.1% |
| Current ratio |
579.3%
|
628.8%
|
554.2% |
| Return on equity (ROE) |
16.2%
|
11.7%
|
16.2% |
| Change turnover |
21,346
|
63,525
|
22,438 |
| Change turnover % |
8%
|
33%
|
12% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.